Network pharmacological analysis of corosolic acid reveals P4HA2 inhibits hepatocellular carcinoma progression.

Fei-Feng TangLong LiuXiao-Ting TianNing LiYing-Xiu PengChun-Mei QianTing-Ting JiaJing-Jin LiuWen-Hui GaoYan-Feng Xu

Published in: BMC complementary medicine and therapies (2023)

Our results indicate that P4HA2 is a potential target of corosolic acid. Thus, they contribute to understanding molecular changes in HCC after corosolic acid treatment and facilitate finding new treatment regimens.

Keyphrases

combination therapy
human health